Infant Bacterial Therapeutics AB ("IBT"), a subsidiary of BioGaia AB, announces the appointment of Daniel Mackey as chief financial officer from January 2017.
IBT appoints new CFO
Staff Writer | Stockholm, Sweden | Thursday October 13, 2016 6:21AM ET
Article continues below READ MORE Hill & Smith Holdings appoints Mark Reckitt as director
Mr. Mackey has 20 years experience from diverse U.S. and international management positions in finance and accounting with Investors Bank & Trust Co., Nordea Investment Management AB and Nordea Bank AB.
He is replacing Michael Owens in this role.
Mr. Owens will continue as financial controller of the company.
LATEST MOVES FROM Sweden